• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,493.54 504.86
( 0.65%)
Global Indices
Nasdaq
49,467.44 867.71
(1.79%)
Dow Jones
7,146.92 84.64
(1.20%)
Hang Seng
58,837.37 -680.97
(-1.14%)
Nikkei 225
10,660.47 70.48
(0.67%)
Forex
USD-INR
93.19 -0.12
(-0.13%)
EUR-INR
109.85 -0.18
(-0.16%)
GBP-INR
126.25 -0.31
(-0.25%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Dipna Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543594
INE0MC401013
15.7559345
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
24.78
24.11
EPS(TTM)
Face Value()
Div & Yield %
0.37
10
0
 

IDBI Bank total business rises 14% YoY to Rs 6 lakh crore in Q4 FY26
Apr 06,2026
On a sequential basis, the bank’s total business rose around 10% QoQ.

The bank's total deposits stood at Rs 3,46,998 crore in Q4 FY26, recording a growth of around 12% YoY and 12.7% QoQ.

During the quarter, net advances stood at Rs 2,53,538 crore, registering a growth of around 16% YoY and 6.2% QoQ. CASA deposits were at Rs 1,54,873 crore, up around 7% YoY and 14.2% QoQ.

IDBI Bank is engaged in the business of monetary intermediation of commercial banks, saving banks, postal savings banks, and discount houses.

The bank’s standalone net profit jumped 97.5% to Rs 3,627.36 crore on a 9.6% rise in total income to Rs 9,593.64 crore in Q2 FY26 over Q2 FY25.

The counter fell 1.35% to Rs 68.58 on the BSE.